| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/06/2006 | EP1455579B1 Pyrazoles-pyrimidine fungicides |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | CN1829715A Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 09/06/2006 | CN1829714A Pna单体和前体 Pna monomers and precursors |
| 09/06/2006 | CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829708A Piperidine compounds and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829704A Benzo [1,2,5] thiadiazole compounds as CCK2 modulators |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273451C Piperidine MCH antagonists and their use in treatment of obesity |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | USRE39266 5-[4-[2-[2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl]ethoxy]phenyl methyl]thiazolidine-2,4-dione; intermediate compound for antidiabetic drug |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102005 Diagnosing the presence or absence of polyneuropathy by assessing the presence or absence of antibodies which bind to a heparin oligosaccaride; quantitative analysis by enzyme-linked immunoabsorbent assay; kits |
| 09/05/2006 | US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101886 such as N-{2-[2-(4-1,2-Benzisothiazol-3-yl-piperazin-1-yl)-ethyl]-phenyl}-2-(2,5-dimethoxy-phenyl)-acetamide; antagonists of dopamine D2 receptors and of serotonin 2A (5HT2a) receptors; for treatment of depression and dementia/schizophrenia |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101880 Peptidic compounds as cysteine protease inhibitors |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101874 1) N-[[(5S)-3-[4-(2,3-dihydro-1,1-dioxido-4H-1,4-thiazin-4-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; potent activities against Gram-positive and Gram-negative bacteria |
| 09/05/2006 | US7101869 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 08/31/2006 | WO2006091716A2 Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | WO2006090915A1 Pyridyl acetic acid compounds |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090244A1 New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them |
| 08/31/2006 | WO2006089872A1 Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/31/2006 | WO2006074388A3 TRICYCLIC δ-OPIOID MODULATORS |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/31/2006 | WO2006060029A3 Insecticidal n-substituted sulfoximines |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194970 Process for producing imide compound |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194846 neurodegenerative diseases; ischemic stroke, traumatic brain injury, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, senile dementia, spinal cord injury, restless legs syndrome, Huntington's disease, Parkinson's disease, irritable bowel disease and inflammatory bowel diseases, Crohn's disease, |
| 08/31/2006 | US20060194844 2-Acylaminothiazole derivative or salt thereof |
| 08/31/2006 | US20060194842 Oxyindole derivatives |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194802 suc as 5-[4-(2,5-Dichloro-phenoxy)-3-fluoro-phenylamino]-3-hydroxy-N-isopropyl-isothiazole-4-carboxamidine; anticarcinogenic agent |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194788 N-(5-ethyl-5-methyl-4,5,6,7-tetrahydro-benzothiazole-2-yl)-guanidine or its formate, suitable for the treatment of pain and hyperalgesia |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194767 Novel agents for preventing and treating disorders involving modulation of the RyR receptors |
| 08/31/2006 | US20060193926 To treat psychiatric and mood disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity; 2-[1-(3-methoxy-4-pyridin-2-ylphenyl)-1H-pyrrol-3-yl]pyridine; minimal side effects |
| 08/31/2006 | US20060193913 And salts such as the maleate in particulate form, prepared by wet milling; controlled release compositions |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2598934A1 Pyridyl acetic acid compounds |
| 08/31/2006 | CA2598838A1 Multimediator 5-ht6 receptor antagonists, and uses related thereto |
| 08/31/2006 | CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | CA2597460A1 Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| 08/31/2006 | CA2595257A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695969A1 Alpha-amino acid derivatives and use thereof as medicines |
| 08/30/2006 | EP1695967A1 Processes for production of pyrimidine derivatives and intermediates |
| 08/30/2006 | EP1695964A1 Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694799A2 Process for upgrading naphtha |
| 08/30/2006 | EP1694673A1 Novel thiazole derivates |
| 08/30/2006 | EP1694671A2 Quinoxalines useful as inhibitors of protein kinases |
| 08/30/2006 | EP1694668A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 08/30/2006 | EP1694665A2 Substituted thiophenes |
| 08/30/2006 | EP1694659A1 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 08/30/2006 | EP1694655A2 Phosphodiesterase inhibitors |
| 08/30/2006 | EP1694649A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 08/30/2006 | EP1694646A1 Process for the synthesis of pioglitazone hydrogen chloride |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826338A Therapeutic agent for senile dementia |
| 08/30/2006 | CN1826337A Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone and method thereof |